Your session is about to expire
← Back to Search
Visual Feedback Monitoring for Obesity
N/A
Waitlist Available
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks
Awards & highlights
Study Summary
This trial is testing a new exercise monitoring system that could help people with obesity meet aerobic exercise guidelines independently with reduced risk of injury.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Energy expenditure
Secondary outcome measures
Heart rate
Maximum hip flexion
Tibial positive peak acceleration
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active-Sedentary ExperimentalExperimental Treatment1 Intervention
Group II: Active-Sedentary ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Mississippi Medical CenterLead Sponsor
175 Previous Clinical Trials
195,444 Total Patients Enrolled
9 Trials studying Obesity
559 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a body mass index (BMI) ranging from 30 to 40, which is considered overweight or obese.You have a health condition or injury that makes it difficult to walk on a treadmill.You have indications of heart, lung, metabolic, or kidney problems.
Research Study Groups:
This trial has the following groups:- Group 1: Active-Sedentary Control
- Group 2: Active-Sedentary Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger